Tanya Simuni, MD, was awarded a grant from the National Institutes of Health to conduct a $16 million phase III study of the safety and efficacy of the drug isradipine as a potential neuroprotective agent in Parkinson’s disease.
Developed by Gregory Dumanian, MD, and Todd A Kuiken, MD, PhD, targeted muscle reinnervation enables an amputee to control motorized prosthetic devices and regain sensory feedback. New research also shows that it reduces neuroma pain from cut nerve endings.
The effort has already combined more than a million patient records in the Windy City and recently received a $7 million grant from the Patient-Centered Outcomes Research Institute.
A newly funded study will be used to identify brain and behavioral indicators at preschool age that predict whether or not early onset mental health problems persist through adolescence.
An intravaginal ring, developed by Northwestern scientist Patrick Kiser, is the first device to be tested in women with the potential to protect against HIV, herpes and unwanted pregnancy.
David Liss, PhD, found that more comprehensive primary care reduced specialist referrals in patients with treated hypertension, helping to ensure that specialists are seeing the patients who would benefit most from their expertise.
Study is the first to show sedentary behavior is its own risk factor for disability, separate from lack of moderate vigorous physical activity.
Yeongchi Wu, MD, has spent more than a decade perfecting a sustainable and cost-effective manner to create prosthetics and orthotics in the developing world.
Dimitri Krainc and Andrew Parsa had only heard of each other before they came to Northwestern Medicine. Now they share a vision as new leaders for the academic and clinical missions in neurology and neurosurgery.
More than 90 percent of adult social media users surveyed in a recent study would share their health records anonymously to help improve the care they and future patients receive, as well as to support medical research.